Press Room

IFPAC® Cortona Conference 2023

Start
Sunday, October 08, 2023
End
Wednesday, October 11, 2023
Location: Cortona, Italy

Join Hovione at IFPAC® - Cortona 2023

The conference covers the latest in Advanced Manufacturing technology and innovation for the pharmaceutical and biotechnology industries and is the place to be to successfully review progress in the field, hear case studies & share resources on improving manufacturing control, process optimization, and data management. 

Filipe Gaspar - VP Technology Intensification will be co-chairing the Continuous Tableting session and on Tuesday, 10 October (3:30 pm) will also provide a presentation entitled “Steps to Accelerate Adoption of Continuous Tableting for Oral Solid Dosage Drug Products: A CDMO Perspective” where he will describe Hovione’s experience in continuous manufacturing, the value proposition of continuous tableting, its current shortcomings and the key programs in place at Hovione to overcome these challenges. 

schedule a meeting

 

 

 

 

Schedule your meeting today 

Find out more about Continuous Tableting at Hovione

Find more about IFPAC Cortona 

 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025